Skip to main navigation Skip to search Skip to main content

WT ISSF 15/16 To assess the potentials of using ModCell to assess genes that mediate cetuximab resistance in preclinical models and its usefulness in recurrent or metastatic HNSCC patients

Project Details

Short titleWT ISSF 15/16 To assess the potentials of using ModCell to assess genes that mediate cetuximab resistance in preclinical models and its usefulness in recurrent or metastatic HNSCC patients
StatusFinished
Effective start/end date1/07/16 → 31/10/16

Funding

  • Wellcome Trust